康杰克寡糖通过5-HT4R/cAMP/PKA/p-CREB通路激活缓解小鼠的便秘
Guang-Jun Sun1,2,3, Ming Li4, Xiao-Yu Zhang1,2,3
1Department of Proctology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China.
康杰克寡糖 (KOS) 通过激活5-HT4R/cAMP/PKA/p-CREB通路来缓解便秘. 这种机制涉及促进平滑肌肉细胞的增殖,
科学领域:
- 胃肠病学
- 药理学
背景情况:
- 康杰克寡糖 (KOS) 具有松作用.
- 需要阐明KOS药作用背后的确切机制.
研究的目的:
- 研究KOS药作用的潜在机制.
- 确定5-HT4R/cAMP/PKA/p-CREB途径在KOS介导的便秘缓解中的作用.
主要方法:
- 野生类型和5-HT4R绝杀小鼠的洛帕胺诱导便秘模型.
- 对便秘参数,胃肠道激素和Ca2+度的分析.
- 使用免疫光,西式涂抹和免疫组织化学对5-HT4R/cAMP/PKA/p-CREB途径的研究.
主要成果:
- KOS有效地缓解了洛佩拉引起的便秘.
- 在便秘小鼠中,KOS激活了5-HT4R/cAMP/PKA/p-CREB信号通路.
- 在5-HT4R淘汰小鼠中,KOS的药效果显著降低,这表明该途径的依赖性.
结论:
- 通过激活5-HT4R/cAMP/PKA/p-CREB信号通路,KOS可以改善便秘.
- 通过这种途径,KOS促进平滑肌肉细胞的增殖,从而有助于其松作用.
更多相关视频
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
